0001666071-23-000138.txt : 20231003 0001666071-23-000138.hdr.sgml : 20231003 20231003182710 ACCESSION NUMBER: 0001666071-23-000138 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231001 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Temsamani Karim Saad CENTRAL INDEX KEY: 0001944491 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 231305852 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wk-form4_1696372021.xml FORM 4 X0508 4 2023-10-01 0 0001666071 Cardlytics, Inc. CDLX 0001944491 Temsamani Karim Saad 675 PONCE DE LEON AVE. NE SUITE 6000 ATLANTA GA 30308 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-10-01 4 M 0 50000 A 243768 D Common Stock 2023-10-02 4 S 0 15463 13.55 D 228305 D Common Stock 2023-10-02 4 S 0 8299 14.92 D 220006 D Common Stock 2023-10-02 4 S 0 4708 15.70 D 215298 D Common Stock 2023-10-02 4 S 0 106 16.35 D 215192 D Restricted Stock Units 2023-10-01 4 M 0 50000 0 D Common Stock 50000 100000 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.21 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.27 to $15.265, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.275 to $16.23, inclusive. This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023 and October 1, 2023. An additional 25% of the RSU award shall vest on each of January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date. /s/ Jason Minio, Attorney-in-Fact 2023-10-03